Data S3. Overall, disease-free, disease-specific and progression-free survival curves plotted across 33 cancer types according to the expression level of bone morphogenetic proteins.
This dataset includes patient data from the LANCE study to facilitate reproducibility and data reuse. The data encompasses patient outcomes in terms of overall survival and progression-free survival,
Raw runtimes for the program performance for burden based analyses, driver gene analysis, and clinical exploratory programs. Also includes runtimes for skew and scalability experiments.
